Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience. Elwazir M, Krause ML, Bois JP, Christopoulos G, et al. J Card Fail 2022;28:247-258.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Elwazir M, Krause ML, Bois JP, Christopoulos G, et al. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience. J Card Fail 2022;28:247-258.
PMID: 34320381